Martin Widschwendter

23.0k total citations · 2 hit papers
184 papers, 10.4k citations indexed

About

Martin Widschwendter is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Martin Widschwendter has authored 184 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 47 papers in Genetics and 43 papers in Cancer Research. Recurrent topics in Martin Widschwendter's work include Epigenetics and DNA Methylation (88 papers), Ovarian cancer diagnosis and treatment (28 papers) and Cancer Genomics and Diagnostics (21 papers). Martin Widschwendter is often cited by papers focused on Epigenetics and DNA Methylation (88 papers), Ovarian cancer diagnosis and treatment (28 papers) and Cancer Genomics and Diagnostics (21 papers). Martin Widschwendter collaborates with scholars based in United Kingdom, Austria and United States. Martin Widschwendter's co-authors include Andrew E. Teschendorff, Heidi Fiegl, Christian Marth, Hannes Müller, Peter A. Jones, Hans H. Goebel, Allison Jones, Elisabeth Müller‐Holzner, Ian Jacobs and Andreas Widschwendter and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Martin Widschwendter

179 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic stem cell signature in cancer

2006 775 citations Martin Widschwendter, Heidi Fiegl et al. profile →
Cervical cancer screening using DNA methylation triage in a real-world population

2024 44 citations James E. Barrett, Jiangrong Wang et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Widschwendter United Kingdom	55	7.6k	2.5k	2.1k	1.8k	915	184	10.4k
Takuya Moriya Japan	52	3.1k 0.4×	1.7k 0.7×	2.7k 1.3×	2.1k 1.2×	1.3k 1.4×	336	9.3k
Hani Gabra United Kingdom	44	3.2k 0.4×	1.4k 0.6×	2.4k 1.1×	986 0.5×	2.2k 2.4×	174	7.4k
Diether Lambrechts Belgium	53	6.3k 0.8×	2.8k 1.1×	3.9k 1.8×	1.2k 0.7×	716 0.8×	296	14.4k
Anna DeFazio Australia	35	2.9k 0.4×	1.5k 0.6×	2.9k 1.4×	1.2k 0.7×	2.1k 2.3×	123	6.5k
Susan J. Clark Australia	65	11.2k 1.5×	3.4k 1.4×	1.1k 0.5×	2.1k 1.2×	232 0.3×	202	14.5k
Jörg Tost France	52	6.0k 0.8×	1.6k 0.6×	874 0.4×	1.6k 0.9×	205 0.2×	189	8.9k
Alan Ashworth United Kingdom	68	9.3k 1.2×	4.4k 1.8×	5.7k 2.7×	3.6k 2.0×	760 0.8×	162	15.8k
Silvano Bòsari Italy	56	4.6k 0.6×	2.5k 1.0×	2.8k 1.3×	526 0.3×	410 0.4×	189	9.4k
Lucio Miele United States	79	10.8k 1.4×	3.6k 1.4×	5.4k 2.5×	1.2k 0.7×	439 0.5×	276	18.2k
Cristin G. Print New Zealand	40	3.7k 0.5×	1.4k 0.6×	1.1k 0.5×	669 0.4×	1.2k 1.3×	149	7.8k

Countries citing papers authored by Martin Widschwendter

Since Specialization

Citations

This map shows the geographic impact of Martin Widschwendter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Widschwendter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Widschwendter more than expected).

Fields of papers citing papers by Martin Widschwendter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Widschwendter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Widschwendter. The network helps show where Martin Widschwendter may publish in the future.

Co-authorship network of co-authors of Martin Widschwendter

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Widschwendter. A scholar is included among the top collaborators of Martin Widschwendter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Widschwendter. Martin Widschwendter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herzog, Chiara, Allison Jones, Iona Evans, et al.. (2025). Systems epigenetic approach towards non-invasive breast cancer detection. Nature Communications. 16(1). 3082–3082. 3 indexed citations

Tevini, Julia, Sepideh Aminzadeh-Gohari, Daniela D. Weber, et al.. (2024). A validated HPLC-MS/MS method for the quantification of systemic mifepristone after subcutaneous application in mice. Analytical Methods. 16(31). 5459–5466. 2 indexed citations

Herzog, Chiara, Allison Jones, Iona Evans, et al.. (2024). Cigarette Smoking and E-cigarette Use Induce Shared DNA Methylation Changes Linked to Carcinogenesis. Cancer Research. 84(11). 1898–1914. 25 indexed citations

Barrett, James E., Jiangrong Wang, Chiara Herzog, et al.. (2024). Cervical cancer screening using DNA methylation triage in a real-world population. Nature Medicine. 30(8). 2251–2257. 44 indexed citations breakdown →

Newton, Claire, Viola Liberale, Matthew Burnell, et al.. (2024). Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer. Journal of Obstetrics and Gynaecology. 44(1). 2344529–2344529. 1 indexed citations

Barrett, James E., Chiara Herzog, Charlotte D. Vavourakis, et al.. (2024). High performance of the DNA methylation‐based WID‐qEC test for detecting uterine cancers independent of sampling modalities. International Journal of Cancer. 155(5). 800–806. 3 indexed citations

Herzog, Chiara, Charlotte D. Vavourakis, James E. Barrett, et al.. (2023). HPV‐induced host epigenetic reprogramming is lost upon progression to high‐grade cervical intraepithelial neoplasia. International Journal of Cancer. 152(11). 2321–2330. 3 indexed citations

Herzog, Chiara, Karin Sundström, Allison Jones, et al.. (2022). DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test. Clinical Epigenetics. 14(1). 150–150. 6 indexed citations

Barrett, James E., Allison Jones, Iona Evans, et al.. (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. Nature Communications. 13(1). 448–448. 32 indexed citations

10.

Sroczynski, Gaby, et al.. (2020). A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies. Cancer Prevention Research. 13(5). 429–442. 12 indexed citations

11.

Wegwarth, Odette, et al.. (2018). What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. BMJ Open. 8(12). e023789–e023789. 18 indexed citations

12.

Levine, Morgan E., Ake T. Lu, Brian H. Chen, et al.. (2016). Menopause accelerates biological aging. Proceedings of the National Academy of Sciences. 113(33). 9327–9332. 319 indexed citations

13.

Tan, YingMeei, Dahui Sun, Kathleen Klotz‐Noack, et al.. (2014). PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer. Cancer Research. 74(7). 2006–2014. 18 indexed citations

14.

Nunes, Natalie, et al.. (2012). A randomised controlled trial comparing surgical intervention rates between two protocols for the management of asymptomatic adnexal tumours in postmenopausal women. BMJ Open. 2(6). e002248–e002248. 5 indexed citations

15.

Fiegl, Heidi, Allison Jones, Cornelia Hauser‐Kronberger, et al.. (2008). Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer. Clinical Cancer Research. 14(11). 3494–3502. 32 indexed citations

16.

Fiegl, Heidi, Simone Millinger, Elisabeth Mueller‐Holzner, et al.. (2005). Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients. Cancer Research. 65(4). 1141–1145. 208 indexed citations

17.

Widschwendter, Andreas, Hannes Müller, Heidi Fiegl, et al.. (2004). DNA Methylation in Serum and Tumors of Cervical Cancer Patients. Clinical Cancer Research. 10(2). 565–571. 100 indexed citations

18.

Widschwendter, Martin, Guanchao Jiang, Christian B. Woods, et al.. (2004). DNA Hypomethylation and Ovarian Cancer Biology. Cancer Research. 64(13). 4472–4480. 186 indexed citations

19.

Widschwendter, Martin, Kimberly D. Siegmund, Hannes Müller, et al.. (2004). Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen. Cancer Research. 64(11). 3807–3813. 268 indexed citations

20.

Daxenbichler, G., Martin Widschwendter, & Christian Marth. (1996). Sensitivity of Breast and Ovarian Cancer Cells for Interferons (IFNs) and Retinoids. Annals of the New York Academy of Sciences. 784(1). 294–303. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact